Bayer CropScience Limited.
₹3,263.00-₹19.40 (-0.6%)
Last close · Data as of Oct 30, 2026
- Market cap
- ₹19,912 Cr
- P/E
- 32.7x
- EV / EBITDA
- 18.5x
- Revenue
- ₹5,473 Cr
- Net margin
- 14.5%
- ROCE
- 33.1%
Price chart
Technical chartScreen technicals →-33.6% over the last year
Daily closes.
Go deeper
Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools
Performance
Price change over each period, before dividends.
- 1M
- -10.1%
- 3M
- -22.7%
- 6M
- -31.6%
- 1Y
- -33.6%
- 5Y
- -31.6%
52-week range
Day change -₹19.40 (-0.6%) from ₹3,282 to ₹3,263 · Last close Oct 30, 2026
Best weekday to invest, historically
The same weekly amount in BAYERCROP, bought on each weekday since 2021.
AI Summary
Indian StockStrengths1
- Healthy return on equity of 26.0%
Concerns1
- Net profit declined 23.2% year-over-year
Rule-based from financial data. Not advice.
About the company
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and hybrid corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance imaging devices.
Read moreShow less
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and hybrid corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as well as sells and distributes row crop hybrid seeds. Further, it provides digital farming products comprising FarmRise and other digital applications, as well as tools, including remote sensing, IoT sensors, GPS, drones, artificial intelligence, and data analytics to monitor and manage crop growth, soil health, and weather conditions. The company also exports its products. Bayer CropScience Limited was founded in 1896 and is based in Thane, India.
- Sector
- Materials
- Shares outstanding
- 4.5 Cr shares
- ISIN
- INE462A01022
- BSE code
- 506285
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- ₹19,912 Cr
- P/E
- 32.7x
- P/B
- 6.4x
- EV / EBITDA
- 18.5x
- EV / Sales
- 3.8x
- P/S
- 3.9x
- Earnings yield
- 3.1%
- 52-week high
- ₹5,025.05
- 52-week low
- ₹3,261.45
Profitability
- Operating margin
- 18.8%
- Net margin
- 14.5%
- EBITDA margin
- 20.3%
- ROE
- 26.0%
- ROCE
- 33.1%
- ROA
- 16.1%
- Dividend payout
- 85.0%
- Tax rate
- 21.0%
- Other income, % of PBT
- 8.1%
Growth
- RevenueLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹5,473 Cr
- Revenue growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 7.2%
- Revenue CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 7.2%
- EBITDALatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹1,035 Cr
- EBITDA growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -5.2%
- Net profit growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -23.2%
- Net profit CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 9.3%
- Cash from operationsLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹952 Cr
- CFO growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 56.3%
- Free cash flowLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -₹272 Cr
- Asset growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -1.8%
Solvency and efficiency
- Current ratio
- 2.39
- Debt / Equity
- 0.02
- Debt / Assets
- 0.01
- Debt / EBITDA
- 0.05
- Interest coverage
- 47.95
- Financial leverage
- 1.61
- CFO / Net profit
- 1.29
- Cash / Market cap
- 20.1%
- Cash per share
- ₹891.74
- Asset turnover
- 1.11
- Fixed asset turnover
- 12.33
- Capital intensity
- 0.08
- Debtor days
- 69 days
- Inventory turnover
- 1.64
- Cash conversion cycle
- 204 days
Where the revenue went
Of every ₹100 of FY2025 revenue, ₹10 was left as net profit.
| From | To | Amount |
|---|---|---|
| Sales | Expenses | ₹4,782 Cr |
| Sales | Operating profit | ₹691 Cr |
| Operating profit | Interest | ₹17 Cr |
| Operating profit | Depreciation | ₹85 Cr |
| Operating profit | Profit before tax | ₹589 Cr |
| Other income | Profit before tax | ₹118 Cr |
| Profit before tax | Tax and other | ₹139 Cr |
| Profit before tax | Net profit | ₹568 Cr |
Revenue and net profit
Revenue grew 7.2% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2021 | ₹4,261 Cr | ₹493 Cr |
| FY2022 | ₹4,734 Cr | ₹645 Cr |
| FY2023 | ₹5,140 Cr | ₹758 Cr |
| FY2024 | ₹5,106 Cr | ₹740 Cr |
| FY2025 | ₹5,473 Cr | ₹568 Cr |
Cash flows
FY2025: ₹262 Cr from operations, ₹348 Cr free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2021 | ₹687 Cr | ₹694 Cr |
| FY2022 | ₹216 Cr | ₹280 Cr |
| FY2023 | ₹609 Cr | ₹692 Cr |
| FY2024 | ₹952 Cr | ₹952 Cr |
| FY2025 | ₹262 Cr | ₹348 Cr |
Growth
Latest fiscal year FY2025 (ending March): each figure with its change over the year before.
- Revenue
- ₹5,473 Cr+7.2%1Y
- Net profit
- ₹568 Cr-23.2%1Y
- Cash from operations
- ₹262 Cr
- Free cash flow
- ₹348 Cr-63.4%1Y
- Revenue CAGR, 5Y
- 7.2%
- EBITDA CAGR, 5Y
- 9.3%
- Net profit CAGR, 5Y
- 9.3%
| Year | Revenue | Operating income | EBITDA | Net profit | CFO | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹5,473 Cr | ₹691 Cr | — | ₹568 Cr | ₹262 Cr | ₹348 Cr | 19.9% | +7.2% | -23.2% |
Monthly returns
Month-by-month returns of BAYERCROP across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Liabilities and equity | ₹5,246 Cr |
| Equity capital | ₹45 Cr |
| Reserves | ₹2,806 Cr |
| Borrowings | ₹105 Cr |
| Other liabilities | ₹2,290 Cr |
| Assets | ₹5,246 Cr |
| Fixed assets | ₹470 Cr |
| Capital work in progress | ₹119 Cr |
| Investments | ₹35 Cr |
| Other assets | ₹4,622 Cr |
Market cap against peers
8 peers: same sector group, nearest by size.
P/E against peers
BAYERCROP trades at 32.7x earnings against a peer median of 35.5x.
Not shown (no positive earnings and no EV / Sales): KIOCL Limited.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Bayer CropScience Limited.BAYERCROPthis company | ₹19,912 Cr | 32.7x | 6.4x | 26.0% | 18.5x |
| Shyam Metalics and Energy LimitedSHYAMMETL | ₹22,691 Cr | 43.5x | 3.7x | 6.3% | 30.4x |
| SUMITOMO CHEMICAL INDIA LIMITEDSUMICHEM | ₹22,020 Cr | 40.7x | 6.9x | 15.2% | 37.9x |
| KIOCL LimitedKIOCL | ₹22,004 Cr | — | 13.3x | -4.3% | -995.6x |
| Deepak Nitrite LimitedDEEPAKNTR | ₹21,434 Cr | 101.0x | 6.8x | 14.7% | 32.6x |
| Kansai Nerolac PaintsKANSAINER | ₹18,778 Cr | 28.4x | 2.9x | 20.9% | 10.4x |
| Gujarat Mineral Development CorporaGMDCLTD | ₹18,131 Cr | 27.5x | 2.7x | 9.8% | 19.5x |
| Atul Limited.ATUL | ₹18,048 Cr | 37.0x | 3.1x | 7.6% | 25.5x |
| Chambal Fertilisers & Chemicals LtdCHAMBLFERT | ₹17,739 Cr | 9.6x | 1.8x | 18.7% | 7.8x |
| Peer median | — | 35.5x | 3.7x | 12.9% | 19.2x |
Year-to-date ROI
BAYERCROP since 1 January, against earlier years.
Historical volatility
BAYERCROP's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.
Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2021 | 19.0% |
| FY2022 | 17.0% |
| FY2023 | 18.0% |
| FY2024 | 19.0% |
| FY2025 | 13.0% |
| Line | FY2025 |
|---|---|
| RevenueSales | ₹5,473 Cr |
| Costs | |
| Interest | ₹17 Cr |
| Expenses | ₹4,783 Cr |
| Operating profitOperating Profit | ₹691 Cr |
| Other income and charges | |
| Profit before tax | ₹707 Cr |
| Tax | |
| Net profitNet Profit | ₹568 Cr |
| Per share |
| Line | FY2025 |
|---|---|
| Liabilities and equityTotal Liabilities | ₹5,246 Cr |
| Equity capitalEquity Capital | ₹45 Cr |
| Reserves | ₹2,806 Cr |
| Borrowings | ₹105 Cr |
| Other liabilitiesOther Liabilities | ₹2,290 Cr |
| AssetsTotal Assets | ₹5,246 Cr |
| Fixed assetsFixed Assets | ₹470 Cr |
| Capital work in progressCWIP | ₹119 Cr |
| Investments | ₹35 Cr |
| Other assetsOther Assets | ₹4,622 Cr |
| Line | FY2025 |
|---|---|
| Operating cash flowCash from Operating Activity | ₹262 Cr |
| Investing cash flowCash from Investing Activity | ₹86 Cr |
| Financing cash flowCash from Financing Activity | -₹619 Cr |
| Change in cashNet Cash Flow | -₹272 Cr |
Learn while you research
Academy chapters picked for Bayer CropScience Limited. and the metrics on this page.
- 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
- 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 03 Valuation Multiples ExplainedThis stock trades at a P/E of 32.7, learn when high multiples are justified.6 min read
- 04 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 05 Business Cycles & StocksThese cyclical sectors win and lose in different macro phases.6 min read
- 06 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read